Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) Vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma Meeting Abstract
| Authors: | Robert, C.; Thomas, L.; Garbe, C.; Lebbé, C.; Baurain, J. F.; Testori, A.; Maio, M.; Chen, T.; Hoos, A.; Wolchok, J. |
| Abstract Title: | Phase 3 randomized study of ipilimumab (IPI) plus dacarbazine (DTIC) Vs DTIC alone as first line treatment in patients with unresectable stage III or IV melanoma |
| Meeting Title: | 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011) |
| Journal Title: | European Journal of Cancer |
| Volume: | 47 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2011 Sep 23-27 |
| Meeting Location: | Stockholm, Sweden |
| ISSN: | 0959-8049 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2011-09-01 |
| Start Page: | S657 |
| End Page: | S658 |
| Language: | English |
| ACCESSION: | WOS:000295752802322 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0959-8049(11)72527-8 |
| Notes: | Meeting Abstract: 9318 -- European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos" |
